Key Insights

Highlights

Success Rate

94% trial completion (above average)

Published Results

21 trials with published results (23%)

Research Maturity

65 completed trials (72% of total)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 30/100

Termination Rate

4.4%

4 terminated out of 90 trials

Success Rate

94.2%

+7.7% vs benchmark

Late-Stage Pipeline

29%

26 trials in Phase 3/4

Results Transparency

32%

21 of 65 completed with results

Key Signals

21 with results94% success

Data Visualizations

Phase Distribution

77Total
Not Applicable (27)
P 1 (8)
P 2 (16)
P 3 (15)
P 4 (11)

Trial Status

Completed65
Recruiting10
Withdrawn5
Terminated4
Unknown3
Not Yet Recruiting2

Trial Success Rate

94.2%

Benchmark: 86.5%

Based on 65 completed trials

Clinical Trials (90)

Showing 20 of 20 trials
NCT05604222Phase 4Recruiting

Effect of Behavioral Sleep Intervention on Lower Urinary Tract Symptoms in Older Women

NCT05562388Not ApplicableCompleted

Mandibular Advancement Device and Changes in Nocturia

NCT06091566Not ApplicableRecruiting

Safety and Performance of UCon Bar Electrode for the Treatment of Overactive Bladder (OAB) and Bowel Dysfunction (BD)

NCT05090722Not ApplicableSuspendedPrimary

A Pilot Study to Evaluate PureWick for Nocturia

NCT06797245Not ApplicableRecruiting

APPROVE Trial: Evaluating a Prescription Digital Therapeutic for Treatment of OAB in Women

NCT05874375Not ApplicableRecruiting

UCon Treatment of Overactive Bladder (OAB) in Males

NCT06110091Not ApplicableRecruitingPrimary

Multi-center Trial to Improve Nocturia and Sleep in Older Adults

NCT07124390Not ApplicableNot Yet Recruiting

Electroacupuncture as a Treatment for Refractory Overactive Bladder

NCT05300308Recruiting

Lymphoedema and Nocturia/Nocturnal Polyuria After Pelvic LND for Urogenital Cancer

NCT06508944Phase 4Completed

Efficacy of Vaginal 17β-Estradiol on the Urinary Storage Symptoms in Postmenopausal Women

NCT05597020Phase 4Completed

A Study to Find Out if Daridorexant is Safe and Efficacious in Patients With Insomnia and Comorbid Nocturia

NCT06754189Not ApplicableRecruiting

Safety and Performance of UCon Patch Electrode

NCT06866834Recruiting

Examination of the Effect of Nocturia on Pelvic Floor Symptoms, Sleep Parameters and Quality of Life in Women with Urinary Incontinence

NCT05419830Not ApplicableCompletedPrimary

Sleep, Hypertension, and Nocturia: a Multicomponent Approach for Comorbid Illnesses

NCT06617676Not ApplicableNot Yet Recruiting

Transcutaneous Tibial Nerve Stimulation for Overactive Bladder Syndrome and Associated Gait Changes in Post-menopausal Women

NCT05298384Not ApplicableWithdrawnPrimary

Pathophysiologic Study to Understand and Possibly Treat Nocturia

NCT05404828CompletedPrimary

TUCSON Study: Tackling Underlying Causes of Sleep Related Nocturia Nocturia

NCT04526340Not ApplicableCompletedPrimary

Food and Salt Handling in Diuresis

NCT04433897RecruitingPrimary

Effect of Hormonal Replacement Therapy on Nocturia in Postmenopausal Women

NCT05368246Not ApplicableCompleted

Safety and Performance of UCon for the Treatment of the Symptoms of Overactive Bladder (OAB) / Bowel Dysfunction (BD)

Scroll to load more

Research Network

Activity Timeline